Fulvestrant is the first SERD approved for clinical use to treat advanced and metastatic breast cancer
10.1182/blood-2015-01-621870 77 JaganjacM.MilkovicL.SunjicS
The product ships lyophilised with a Certificate of Analysis (COA), HPLC purity 99 %
In the GHK-Cu formulation, it is specifically used to promote collagen and elastin synthesis, wound healing, reduction of inflammation, and cell renewal
A.DhawanU.BoudeauS.LeiS.CarlomagnoY.KnobelM.et al
Liqun Jiao: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2509 - ESOC25-1069 ORBITAL INFARCTION SYNDROME AFTER ANTERIOR CIRCULATION MECHANICAL THROMBECTOMY - A CASE REPORT Pavan Pai 1 1 Wockhardt Hospital, Mira Road, Mumbai, India Background and Aims: To understand and identify complication of Orbital Infarction Syndrome (OIS) after Anterior circulation Mechanical Thrombectomy (MT) Methods: A 31 year old man presented with acute onset left side weakness of three hours onset with NIHSS 6
